Skip to main content

Month: April 2026

YouTube TV Launches Service with Kinetic Fiber

2026’s only Gold American-Business Award winning fiber ISP offering YouTube TV New Kinetic bundle combines high-speed broadband with flexible live multi-channel live TV LITTLE ROCK, Ark., April 30, 2026 (GLOBE NEWSWIRE) — Kinetic, insurgent fiber-internet provider for homes and businesses, today announced a new offer for eligible residential internet customers, giving consumers a $10 per month discount when they pair YouTube TV with their high-speed internet packages. Eligible Kinetic customers can receive $10 off YouTube TV per month for 12 months.* The offer reflects Kinetic’s continued focus on delivering more value, flexibility and choice to consumers by partnering the broadband network with premium-steaming television experience. “Our customers want a connected home that just works – fast internet, great TV, and no...

Continue reading

Notice on the Annual General Meeting of Shareholders of the AUGA group, AB entity under restructuring on 22 May 2026

AUGA group, AB entity under restructuring (code 126264360, registered office at Konstitucijos pr. 21C, Vilnius, hereinafter referred to as the „Company“), by the initiative and decision of the Board, is convening an Annual General meeting of shareholders on May 22, 2026, at 10:00 a.m., hereinafter referred to as the “Meeting”. The Meeting will be held at the conference room at the business center QUADRUM NORTH, address Konstitucijos ave. 21C, Vilnius. The registration of the shareholders begins at 09.30 a.m. Only those persons who will be shareholders of the Company at the close of the record date of the Meeting may participate and vote at the Meeting. The record date of the Meeting shall be 15 May 2026. Agenda of the Meeting:Consolidated management report of the Company for the year 2025 and independent Auditor’s conclusion except the...

Continue reading

Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease

AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to Alzheimer’s disease  The safety and tolerability profile of AUVELITY in agitation associated with dementia due to Alzheimer’s disease has been established across short-term and long-term trials AUVELITY was developed with FDA Breakthrough Therapy designation and evaluated by the FDA under Priority Review Company to host webcast Friday, May 1, at 8:00 AM Eastern Time NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved AUVELITY® (dextromethorphan HBr and bupropion HCl) for the...

Continue reading

Copenhagen Infrastructure Partners completes acquisition of Ørsted’s European onshore platform – and launches Perigus Energy

A new onshore renewable energy company has launched in Europe: Perigus Energy. Perigus Energy operates in Ireland, Germany, the United Kingdom and Spain with an operational and under construction capacity of 826 MW and a multi-gigawatt development pipeline.CORK, Ireland and COPENHAGEN, Denmark, April 30, 2026 (GLOBE NEWSWIRE) — A new chapter for European onshore renewables begins today with the launch of Perigus Energy, following the completion of Copenhagen Infrastructure Partners’ (CIP) acquisition of Ørsted’s European onshore business, through its fifth flagship fund, CI V. Formerly part of Ørsted, the business takes on a new name, identity and ambition as Perigus Energy. Perigus Energy looks to support Europe’s energy security and transition by developing, building and operating onshore wind, solar and battery storage projects...

Continue reading

TME Pharma publishes its annual financial results and annual report

TME Pharma publishes its annual financial results and annual report Berlin, Germany, April 30, 2026, 20.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for brain cancer and eye diseases, announces today its financial results for the fiscal year ending December 31, 2025. The Annual Report 2025, as approved by the management and supervisory boards on April 30, 2025, is available on TME Pharma’s website (www.tmepharma.com). In June 2025, TME Pharma changed its organizational structure to a virtual company structure to allow it to continue pursuing the goals of financing, licensing or M&A transactions focused on its clinical stage assets, NOX-A12 and NOX-E36 while minimizing costs by outsourcing essentially all functions to maintain the...

Continue reading

Anoto Group AB (publ): Annual Report 2025 publication date update

Anoto Group AB (publ) today announces that the Annual Report for the financial year 2025 will be published no later than 15 May 2026, rather than on the previously communicated date of 30 April. The revised date reflects a later-than-planned start to the audit due to scheduling constraints. Despite the best efforts of the Company and its auditor, the original timetable did not allow sufficient time to complete the audit alongside the translation work required for the Company’s multilingual reporting and the ESEF tagging. The Company has informed Nasdaq Stockholm’s issuer compliance function of the postponement and will publish its Annual Report no later than the 15 May 2026.   The financial calendar on the Company’s website has been updated accordingly. About Anoto Group AB Anoto Group AB (publ) is a Swedish technology...

Continue reading

AUGA group, RAB published Audited Results for 2025

AUGA group, RAB reports 2025 annual results: gross profit returned to EUR 5.36 million (2024: gross loss of EUR 4.94 million), EBITDA surged to EUR 9.99 million (2024: EUR 0.08 million), and net loss narrowed sharply to EUR 9.99 million from EUR 32.56 million — reflecting the first full year of structured restructuring and operational improvement. Financial Results On 30 April 2026, AUGA group, RAB, legal entity code 126264360 (hereinafter – the “Company”) published its audited consolidated financial statements for the year ended 31 December 2025. Full-year sales revenue amounted to EUR 51.48 million, 7% below EUR 55.29 million in 2024. The revenue decline was driven by the Crop growing segment, while Dairy and FMCG both recorded growth.Key Indicator (EUR million) 2025 2024Revenue 51.48 55.29Gross Profit / (Loss) 5.36 (4.94)EBITDA 9.99 0.08EBITDA...

Continue reading

Toll Brothers Announces Grand Opening of Toll Brothers at Oakhill Reserve in Tomball, Texas

New Houston-area luxury community offers single-family homes with exceptional amenities in a premier location TOMBALL, Texas, April 30, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Houston-area community,  Toll Brothers at Oakhill Reserve, is now open in Tomball, Texas. Located at 22414 Decker Prairie Rosehill Road, this highly anticipated community offers two collections of stunning single-family homes on spacious home sites with access to world-class amenities and top-rated Tomball Independent School District schools. Toll Brothers at Oakhill Reserve features an impressive selection of one- and two-story home designs with floor plans ranging from 1,884 to 3,175+ square feet. Homes offer 3 to 5 bedrooms, 2 to 4.5 baths, and 2- to 3-car garages....

Continue reading

LiveOne (Nasdaq: LVO) and Subsidiary PodcastOne (Nasdaq: PODC) Launch PodcastOneAI, Unlocking 200,000+ Hours Across $20B+ AI Training and $40B+ Data Monetization Markets

Positioning Both Companies to Drive High-Margin Revenue Across Hyperscalers, Enterprise, Media and Government LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO) and its subsidiary PodcastOne (Nasdaq: PODC), a leading podcast network and media platform, have launched PodcastOneAI, a proprietary AI platform designed to convert its extensive audio and video catalog into scalable, monetizable assets across the rapidly expanding artificial intelligence ecosystem. PodcastOneAI leverages more than 100,000 hours of premium, brand-safe content to meet increasing demand from hyperscalers, enterprise platforms, media companies and government organizations seeking high-quality training data and licensed content solutions. The platform is structured to generate multiple high-margin revenue streams, including upfront licensing...

Continue reading

Availability of 2025 Universal Registration Document and Procedure for Consulting Preparatory Documents for General Shareholders’ Meeting

AVAILABILITY OF 2025 UNIVERSAL REGISTRATION DOCUMENT AND PROCEDURE FOR CONSULTING PREPARATORY DOCUMENTS FOR GENERAL SHAREHOLDERS’ MEETING April 30, 2026 – The 2025 Universal Registration Document (Document d’Enregistrement Universel) of Publicis Groupe S.A. [Euronext Paris FR0000130577, CAC 40] has been filed with the French Financial Markets Regulatory Authority (AMF) on April 30, 2026. The document can be requested at the Groupe’s Headquarter in accordance with legal and regulatory conditions and is available on the Company’s website: www.publicisgroupe.com and on the AMF website (www.amf-france.org). This Universal Registration Document notably includes the 2025 annual financial report, the management report, the corporate governance report, the sustainability statements and the statutory auditors’ reports. The Prior notice...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.